First Nationwide Advisers LLC boosted its stake in Johnson & Johnson (NYSE:JNJ – Unfastened Record) through 128.8% all through the 3rd quarter, Holdings Channel.com stories. The company owned 10,023 stocks of the corporate’s inventory after purchasing an extra 5,642 stocks all through the length. First Nationwide Advisers LLC’s holdings in Johnson & Johnson had been value $1,561,000 on the finish of the newest quarter.

Different massive buyers have additionally purchased and bought stocks of the corporate. Hibernia Wealth Companions LLC purchased a brand new stake in stocks of Johnson & Johnson all through the 3rd quarter valued at roughly $27,000. FNY Funding Advisers LLC purchased a brand new stake in stocks of Johnson & Johnson all through the 3rd quarter valued at roughly $37,000. Tower View Wealth Control LLC boosted its place in stocks of Johnson & Johnson through 183.3% all through the 3rd quarter. Tower View Wealth Control LLC now owns 255 stocks of the corporate’s inventory valued at $40,000 after buying an extra 165 stocks within the closing quarter. Ingenious Capital Control Investments LLC boosted its place in stocks of Johnson & Johnson through 43.0% all through the 3rd quarter. Ingenious Capital Control Investments LLC now owns 286 stocks of the corporate’s inventory valued at $45,000 after buying an extra 86 stocks within the closing quarter. In the end, VitalStone Monetary LLC purchased a brand new stake in stocks of Johnson & Johnson all through the second one quarter valued at roughly $48,000. 68.40% of the inventory is owned through hedge price range and different institutional buyers.

Johnson & Johnson Inventory Down 0.9 %

Johnson & Johnson inventory opened at $156.55 on Monday. The inventory has a marketplace cap of $376.86 billion, a PE ratio of eleven.34, a price-to-earnings-growth ratio of two.63 and a beta of 0.53. The corporate has a debt-to-equity ratio of 0.37, a handy guide a rough ratio of 0.96 and a present ratio of one.21. Johnson & Johnson has a 12 months low of $144.95 and a 12 months prime of $175.97. The inventory has a fifty day transferring reasonable of $158.21 and a 200 day transferring reasonable of $158.24.

Johnson & Johnson (NYSE:JNJ – Get Unfastened Record) closing posted its quarterly income information on Tuesday, January twenty third. The corporate reported $2.29 EPS for the quarter, beating analysts’ consensus estimates of $2.28 through $0.01. The corporate had income of $21.40 billion all through the quarter, in comparison to analysts’ expectancies of $21.02 billion. Johnson & Johnson had a go back on fairness of 36.75% and a internet margin of 37.79%. Johnson & Johnson’s income for the quarter used to be down 9.7% in comparison to the similar quarter closing 12 months. Throughout the similar quarter within the prior 12 months, the industry earned $2.35 income in step with proportion. As a gaggle, sell-side analysts expect that Johnson & Johnson will publish 10.65 EPS for the present 12 months.

Johnson & Johnson Proclaims Dividend

The corporate additionally not too long ago disclosed a quarterly dividend, which shall be paid on Tuesday, March fifth. Buyers of file on Tuesday, February twentieth shall be given a dividend of $1.19 in step with proportion. This represents a $4.76 dividend on an annualized foundation and a yield of three.04%. The ex-dividend date of this dividend is Friday, February sixteenth. Johnson & Johnson’s dividend payout ratio (DPR) is right now 34.47%.

Wall Boulevard Analyst Weigh In

JNJ has been the subject of a number of analysis stories. StockNews.com upgraded Johnson & Johnson from a “purchase” score to a “strong-buy” score in a analysis file on Tuesday, February sixth. Cantor Fitzgerald reissued an “obese” score and issued a $215.00 goal charge on stocks of Johnson & Johnson in a file on Tuesday, February sixth. Wells Fargo & Corporate downgraded Johnson & Johnson from an “obese” score to an “equivalent weight” score and dropped their goal charge for the inventory from $170.00 to $163.00 in a file on Wednesday, December thirteenth. UBS Crew raised Johnson & Johnson from a “impartial” score to a “purchase” score and boosted their goal charge for the inventory from $167.00 to $180.00 in a file on Friday, December 1st. In the end, TheStreet downgraded Johnson & Johnson from a “b” score to a “c+” score in a file on Friday, November seventeenth. 8 equities analysis analysts have rated the inventory with a dangle score, 5 have given a purchase score and one has assigned a powerful purchase score to the inventory. In keeping with information from MarketBeat, the corporate these days has a consensus score of “Reasonable Purchase” and a consensus goal charge of $176.14.

Learn Our Newest Inventory Research on Johnson & Johnson

Insider Task at Johnson & Johnson

In comparable information, EVP Jennifer L. Taubert bought 59,397 stocks of the corporate’s inventory in a transaction on Friday, February ninth. The inventory used to be bought at a median charge of $156.27, for a complete transaction of $9,281,969.19. Following the finishing touch of the sale, the chief vice chairman now owns 141,416 stocks within the corporate, valued at $22,099,078.32. The transaction used to be disclosed in a report filed with the SEC, which may also be accessed via this link. 0.20% of the inventory is owned through corporate insiders.

About Johnson & Johnson

(Unfastened Record)

Johnson & Johnson, along side its subsidiaries, researches, develops, manufactures, and sells quite a lot of merchandise within the healthcare box international. The corporate’s Client Well being phase supplies pores and skin well being/attractiveness merchandise underneath the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX manufacturers; child care merchandise underneath the JOHNSON’S and AVEENO Child manufacturers; oral care merchandise underneath the LISTERINE logo; TYLENOL acetaminophen merchandise; SUDAFED chilly, flu, and allergic reaction merchandise; BENADRYL and ZYRTEC allergic reaction merchandise; MOTRIN IB ibuprofen merchandise; NICORETTE smoking cessation merchandise; and PEPCID acid reflux disorder merchandise.

Featured Articles

Wish to see what different hedge price range are protecting JNJ? Discuss with HoldingsChannel.com to get the most recent 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Unfastened Record).

Obtain Information & Rankings for Johnson & Johnson Day-to-day – Input your e mail deal with beneath to obtain a concise day by day abstract of the most recent information and analysts’ rankings for Johnson & Johnson and comparable corporations with MarketBeat.com’s FREE day by day e mail publication.